PEG 4000 (Forlax®)
DrugPowder for oral solution. 2 sachets of 4g, from baseline every two weeks over a 4 week treatment period.
NCT Number: NCT00255372
The purpose of this study is to determine whether Forlax® is more effective than placebo in relieving chronic constipation in children who may also suffer from soiling or faecal incontinence.
Looking for future studies?
Notify Me12 month–36 month
All sexes
Interventional
Phase 3
Ramathibodi Hospital, Mahidol University,, Bangkok, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Powder for oral solution. 2 sachets of 4g, from baseline every two weeks over a 4 week treatment period.
Powder for oral solution. 1 sachet of 3.3g lactulose active and 1 sachet of lactulose placebo. From baseline every two weeks over a 4 week treatment period.
Time frame: week 4
Time frame: At every visit
Ipsen
Industry
Polyethylene Glycol Laxative (Macrogol 4000;Forlax®) for Treatment of Chronic Constipation in Children : A Phase III, Bicentric, Randomized, Double-blind, Lactulose Controlled Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06695754
Chronic Constipation
Esplugues de Llobregat, Barcelona, Spain
View Trial DetailsNCT06850415
Chronic Constipation, Colonic Transit
Bangkoknoi, Bangkok, Thailand
View Trial DetailsNCT00391820
Bronchial Diseases, Bronchiolitis
Houston, Texas, United States
View Trial DetailsNCT06989268
Chronic Constipation, Constipation
View Trial Details